Live Cell Imaging Market Size to Represent 9% CAGR By 2023 | Sales Projection, Growth, Share, COVID-19 Impact and Trends Analysis

Live Cell Imaging Market Size, Trends and Growth Analysis By Products (Equipment, Consumables, Software), Technology (Fluorescence Recovery After Photobleaching (FRAP)), Application (Drug Discovery, Cell Biology, Others), End-User, Global Forecast Till 2023

Live Cell Imaging Market Overview

Global live cell imaging market is estimated to grow at approximately 9.0 % CAGR during the forecast period, says Market Research Future . The global live cell imaging market is growing pervasively, witnessing the rising demand. Also, factors such as rising cancer cases and increasing uses of live cell imaging techniques in cancer research drive market growth. Live-cell imaging technique has become increasingly popular in the diagnostics and surgeries for its high content screening systems and microscopes. Moreover, the increasing prevalence of chronic diseases escalates market growth to furthered height.

Increasing funding for the development of imaging technologies to be applied in healthcare and growing government funding in cell-based research propel the growth of this market. Furthermore, the adoption of high content screening techniques in drug discovery and cell biology boosts live cell imaging market growth.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6075

Conversely, prohibitive costs of high-content screening systems and the lack of availability of skilled professionals are significant factors projected to impede live cell imaging market growth. Nevertheless, rising demand for effective therapies to treat complicated disorders would support live cell imaging market growth throughout the analyzed period. Also, growing awareness about the benefits of live cell imaging techniques in cancer detection positively impacts the growth of the live cell imaging market.

Report on the global live cell imaging market provides a thorough assessment of the COVID-19 impact on the current and future market dynamics across various geographies. Starting with an informative market overview, the report explains the market definition and the latest trends prevalent in the industry.

Live Cell Imaging Market Segmentations

By Product, the global live cell imaging market is segmented into Equipment {(Microscopes, Confocal Microscopes, Conventional Microscopes, Advanced Fluorescence Microscopes, Cell Analyzers, Standalone Systems, Image-capturing Devices, and Consumables (Assay Kits, Reagents, Media, others)}, Software, and others.

By Technology, the global live cell imaging market is segmented into Fluorescence Resonance Energy Transfer (FRET), Fluorescence Recovery After Photobleaching (FRAP), High-content Analysis, Fluorescence In Situ Hybridization (FISH),Ratiometric Imaging, Total Internal Reflection Fluorescence Microscopy (TRIF), Multiphoton Excitation Microscopy (MPE), and others.

By Application, the global live cell imaging market is segmented into Stem Cells, Cell Biology, Developmental Biology, Drug Discovery, and others.

By End-User, the global live cell imaging market is segmented into Biotechnological Companies, Pharmaceutical Companies, Hospitals, Diagnostic Laboratories, and others.

Global Live Cell Imaging Market Regional Insights

North America dominates the global live cell imaging market. The largest live cell imaging market share attributes to the increasing prevalence of cancer and technological advances. Besides, factors such as the existing well-established healthcare system and high R&D investments by the public and private sectors drive the regional market growth. Additionally, the presence of major market players and increasing usages of live cell imaging techniques for cancer diagnosis spur the growth of the regional market.

Moreover, high investments in imaging systems and increasing R&D activities to improve the imaging quality and data functionalities fuel the regional live cell imaging market growth. Increase in the insurance coverage and growing reimbursement scenario in the US & Canada fuel the growth of the regional market. The North American live cell imaging market is expected to retain its dominance over the global market live cell imaging throughout the assessment period.

Europe stands second in the global live cell imaging market. The market of live cell imaging is majorly driven by the rising government support for research & development activities and the presence of many notable players in the region. Moreover, the increasing prevalence of chronic diseases and increasing per capita healthcare expenses propel the growth of the regional live cell imaging market.

Besides, the increasing support & funding from regulatory authorities to control the rising prevalence of cancer influence the regional market growth. Also, factors such as the presence of well-established healthcare systems and augmenting demand for innovative diagnosis techniques increase the size of the regional market.

The live cell imaging market in the Asia Pacific region is growing briskly. Factors such as raising awareness about the advantages of live cell imaging systems in the detection & treatment of cancer impact the regional market growth. Moreover, increasing patients suffering from various chronic diseases, alongside government initiatives and rising healthcare reforms, push the regional market growth excellently. Furthermore, increasing healthcare expenses and the resurging economy in the region bolster the growth of the regional market.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/live-cell-imaging-market-6075

Live Cell Imaging Market Competitive Landscape

Highly competitive, the live cell imaging market appears fragmented, with many well-established players forming a competitive landscape. To gain a larger competitive share, market players adopt strategic approaches such as mergers & acquisitions, product & technology launch, expansion, and collaboration. Players make substantial investments to drive the R&D required for innovation and product launch. They also invest in increasing their global footprint and acquiring promising companies from emerging markets.

Live Cell Imaging Market Major Players:

Players active in the global live cell imaging market include Carl Zeiss AG, Leica Microsystems, Nikon Corporation, Molecular Devices, LCC, PerkinElmer, Inc., GE Healthcare, Becton, Dickinson, and Company, Olympus Corporation, Sigma-Aldrich Corporation, Thermo Fischer Scientific, Inc., Danaher Corporation, and BioTek Instruments, among others.

Browse More Healthcare Research Reports at:

Spinal Implants Market: Spinal Implants Market is expected to accumulate revenues at 5.5% CAGR during the forecast period.

3D cell culture market: 3D cell culture market size was valued USD 725.15 million in 2016 and expected to grow at a 25.50% CAGR during the forecast period.

Gene Therapy Market: Gene Therapy Market size was valued USD 524 million in 2018 and is likely to grow at a 40.7% CAGR during the forecast period.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/live-cell-imaging-market-6075

Release ID: 88965505